Searched for
NASAL VACCINES
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Worried about recent rise in COVID-19 cases? Here's how to protect yourself without getting a jabAmidst rising COVID-19 cases in Asia, Yale University researchers have discovered that nasal vaccine boosters offer a safer and more target...
- A nose for wider booster vaccinationThe development of the first nasal Covid vaccine, along with others before it, is an affirmation of India's capacity to provide solutions t...
- What you need to know about getting Bharat Biotech's nasal vaccine iNCOVACCBharat Biotech has recently introduced its intranasal Covid vaccine, which will be given as a booster dose, as concerns about the Covid BF....
- Covid Nasal Vaccine: Here is how to book an appointment for a booster dose on CoWINThe Union Health Ministry has approved Bharat Biotech's intranasal Covid vaccine, iNCOVACC, for use as a booster dose. The vaccine is avail...
- Covid-19 nasal vaccine is here: Price, benefits, all you need to knowBharat Biotech has finally announced the price of its intra nasal vaccine for Covid-19, the first in the world. Here is the price of Bharat...
- Bharat Biotech’s Covid-19 nasal vaccination now available on CoWIN app; Know how can you get itA heterologous booster dose of the nasal vaccination can be given to those who have already received Covishield and Covaxin.
- Easy to use, more effective and cheap, nasal Covid vaccines can be game changer: scientistsEarlier this month, Bharat Biotech announced that its iNCOVACC (BBV154),the world's first intranasal COVID-19 vaccine, has received approva...
- Bharat Biotech expects regulator's nod for intranasal COVID-19 vaccine in August"We will be applying for licenses and (they) should come. If everything goes well, we know by next month (August). You (people) would rathe...
- No more jabs: Nasal Covid vaccines may be the future as they treat the infection right where it startsNasal vaccines are administered, as the name suggests, through the nose.
- The answer to stopping the coronavirus may be up the noseThe currently available Covid-19 vaccines are injected into people’s arm muscles and are highly capable at combating the virus once people ...
- DCGI allows Bharat Biotech to conduct phase-3 trials for Covid's intranasal booster doseThe trials of the Intranasal vaccine will take place at nine different sites of the country.
- Bharat Biotech asked to conduct Phase III trials for its intranasal vaccineThe company had also sought approval from the SEC to use its intranasal vaccine as a booster dose, to which the SEC asked the company to su...
- Putin tests experimental nasal vaccine against Covid-19In recent weeks, Russia has been swept by its highest ever Covid-19 surge, with officials regularly registering record-high numbers of new ...
- Ideal time for booster dose for COVID vaccine is 6 months after 2nd dose: Bharat Biotech MDTaking the Covaxin vaccine by the Prime Minister Narendra Modi showed confidence in Indian Science, he said at the Times Now Summit 2021. "...
- Government panel recommends mixing Bharat Biotech's Covaxin and nasal vaccine in trialsThe subject expert committee (SEC) under India's drug regulator gave its go-ahead to Hyderabad-based Bharat Biotech to conduct the phase 2/...
- Subject expert committee nod to Bharat Biotech’s intranasal vaccine trialsThe company had sought permission to conduct both phase-I and phase-II trials. “However, the SEC has asked the company to present data of p...
- Bharat Bio seeks nod to conduct trials of nasal Covid vaccineBharat Biotech, which has developed India’s indigenous Covid-19 vaccine, Covaxin, has sought regulatory approval to start phase-1 and phase...
Load More
